Fourteen apparently carbapenem-susceptible Pseudomonas aeruginosa clinical isolates that exhibited colonies within the inhibition zone around carbapenem discs were analysed. MICs of carbapenems were determined and the isolates were genotyped by PFGE. Population analysis, one-step selection of carbapenem-resistant mutants and growth curves of progenitors and carbapenem-resistant subpopulations were performed. Agar dilution MICs of imipenem and meropenem ranged from 0.5 to 4 mg l "1 and from 0.25 to 2 mg l "1
INTRODUCTION
Carbapenems, mainly imipenem and meropenem, have been extensively used for the treatment of infections caused by multi-resistant Pseudomonas aeruginosa strains. However, pseudomonads may develop resistance to carbapenems through combined mechanisms such as target inaccessibility, stable derepression of AmpC b-lactamase, overexpression of efflux systems and production of metallob-lactamases (MBLs) (Kohler et al., 1999; Livermore, 2002) . Recent data suggest that almost 15 % of P. aeruginosa isolates are resistant to either imipenem or meropenem (Gales et al., 2006) .
Heteroresistance to carbapenems has been described in population studies of meticillin-resistant staphylococci (Kayser et al., 1989) . Among Gram-negative species, population heterogeneity has been detected in Acinetobacter baumannii as subcolonies within the apparent zone of inhibition in either disc diffusion or Etest assays (Pournaras et al., 2005a) . However, in P. aeruginosa heteroresistance to carbapenems has not been investigated, though a recent study has shown that subpopulations with reduced susceptibility to meropenem may selectively be amplified during exposure to the drug (Tam et al., 2005) . In our hospitals MBL-producing or efflux-pump overexpressing carbapenem-resistant P. aeruginosa isolates have emerged in recent years (Pournaras et al., 2003 (Pournaras et al., , 2005b . These issues prompted the cautious evaluation of susceptibility testing in pseudomonads that were systematically collected in our clinical laboratories. Disc diffusion or Etest results gave indications that heterogeneous populations with reduced susceptibility to carbapenems may exist in a number of P. aeruginosa strains that appear to be carbapenem susceptible by conventional automated susceptibility assays. In the present study we attempted to characterize this nonuniformity in the phenotypic expression of carbapenem resistance among unrelated P. aeruginosa clinical isolates.
METHODS
Bacterial isolates and susceptibility testing. The study included all P. aeruginosa isolates that were recovered consecutively from clinical sites of separate patients at the University Hospital of Larissa from July to October 2005 and exhibited one or a few Abbreviation: MBL, metallo-b-lactamase.
colonies within the apparent zone of inhibition in disc diffusion assays. The isolates were identified using the API 20NE system (bioMérieux).
MICs of imipenem, meropenem and the remaining antipseudomonal antibiotics (amikacin, aztreonam, ciprofloxacin, cefepime, ceftazidime, gentamicin, netilmicin, piperacillin, piperacillin/tazobactam, ticarcillin, tobramycin) were performed by the agar dilution method (Clinical and Laboratory Standards Institute, 2003) . The agar plates for carbapenems were prepared with 2 mg l 21 increments of concentrations from 2 to 32 mg l 21 . MICs of carbapenems were also performed by Etest (AB Biodisk). P. aeruginosa ATCC 27853 was used as a control and susceptibility status was defined according to the interpretative criteria of the Clinical and Laboratory Standards Institute (2005) . The isolates were screened by Etest MBL (AB Biodisk) and imipenem-EDTA double-disc synergy test, in order to identify possible MBL producers.
PFGE assay. PFGE of XbaI-digested genomic DNA of P. aeruginosa isolates was performed with a CHEF-DRIII system (Bio-Rad) and banding patterns were compared to published criteria (Tenover et al., 1995) .
Population analysis. Analysis of the cell subpopulations with reduced susceptibility to carbapenems was performed as described by Tomasz et al. (1991) and Hiramatsu et al. (1997) with some modifications. Briefly, 0.1 ml starting bacterial suspension with an optical density corresponding to McFarland 0.5 and serial dilutions of this were spread onto Muller-Hinton agar (MHA) containing imipenem or meropenem in serial twofold dilutions for concentrations ranging from 0.5 to 128 mg l 21 . Concentrations of imipenem or meropenem between 2 and 32 mg l 21 were made with 2 mg l 21 increments to detect more precisely the changes in the susceptibilities of the heteroresistant populations. Tenfold serial dilutions of the starting bacterial suspension were also plated onto drug-free MHA to determine the exact size of the inoculum. The plates were incubated at 37 uC for 48 h before the c.f.u. were counted. The analysis was performed twice for all isolates and the mean values were estimated. The number of resistant cells in the 0.1 ml starting cell suspension was calculated and plotted on a semi-logarithmic graph. The stability of the heterogeneous subpopulations carbapenem MIC was tested by agar dilution with 2 mg l 21 increments, after subculturing the colonies for one week in a drug-free medium. Population analysis of the tested isolates was compared with a carbapenem-susceptible P. aeruginosa isolate with a large inhibition zone and no subcolonies in the disc diffusion assay (PA3240, MICs of 1 mg imipenem l 21 and 0.5 mg meropenem l 21 ), a carbapenem-resistant P. aeruginosa isolate (PA105, MICs of 64 mg imipenem l 21 and 32 mg meropenem l 21 ) and P. aeruginosa ATCC 27853.
One-step selection of imipenem-resistant mutants. To test whether the parental P. aeruginosa isolates have the capacity to generate carbapenem-resistant mutants, a one-step imipenem selection assay was performed. A 0.1 ml portion of approximately 10 8 c.f.u. ml 21 cell suspension was spread on MHA containing 8 mg imipenem l 21 and tenfold serial dilutions were plated on drug-free medium to determine the size of the inoculum. The plates were incubated at 37 uC for 48 h and screened. The frequency of emergence of imipenem resistance was calculated by dividing the number of c.f.u. on the imipenem containing agar by the inoculum size.
Growth curves of bacterial isolates. Growth curves were determined by diluting 0.1 ml overnight culture of the progenitor strains and their respective resistant subpopulations in 15 ml Muller Hinton broth, followed by incubation at 37 uC for 10 h under constant shaking. A volume of 0.1 ml was diluted tenfold serially to 10 26 every 30 min and 0.1 ml each dilution was plated on MHA and incubated for 18 h in 37 uC. The number of c.f.u. were counted and plotted on a semi-logarithmic graph.
RESULTS
During the study period, 14 non-repetitive P. aeruginosa isolates were collected, in which one or a few subcolonies appeared within the zone of inhibition of both carbapenems. These isolates represented 27.5 % of the apparently (Fig. 1) . PFGE patterns of the resistant and native populations were identical, eliminating the possibility that mixed cultures were responsible for the findings observed. The ratio of heterogeneity ranged from 6.9610 25 to 1.2610 27 for imipenem and 2.1610 25 to 1.1610 27 for meropenem as calculated from the colonies grown in the highest concentration of each carbapenem ( Table 2 ). Susceptibility testing on these colonies revealed MICs that ranged from 10 to 20 mg l 21 for imipenem and 4 to 14 mg l 21 for meropenem (Table 2 ). In the resistant subclones MICs of ceftazidime were within the susceptible range (1 to 4 mg l 21 ) being equal to or different by one dilution from their native isolates, implying that AmpC overproduction does not contribute to heteroresistance. However, resistant subclones from all but three ciprofloxacin-susceptible native isolates, formed on either imipenem or meropenem agar plates, showed a fourfold increase in the MIC of ciprofloxacin, suggesting the potential contribution of efflux pump systems.
At the one-step 8 mg l 21 selection of imipenem-resistant mutants, growth was observed in all 14 P. aeruginosa isolates at frequencies ranging from 3.8610 24 to 5.1610 27 . No growth was detected for the carbapenem-susceptible PA3240 and ATCC 27853 strains. Growth curves showed in all cases a prolonged lag phase and a short exponential phase for the heterogeneous subpopulations in comparison with their respective native populations (Fig. 2) , indicating that an increase of the incubation time in phenotypic tests is needed in order to detect resistant subpopulations.
DISCUSSION
Heteroresistance in its broadest sense may represent mixed populations of drug-resistant and drug-susceptible cells of a single bacterial strain (Rinder, 2001) . However, among different pathogens and antimicrobials, detection of heteroresistance may be affected by variables such as the screening method, test conditions, local epidemiology, antibiotic selective pressure and the unstable nature of the resistance phenotype (Tomasz et al., 1991; Yamazumi et al., 2003; Plipat et al., 2005) . This is to the best of our knowledge the first report that characterizes heterogeneous subpopulations with reduced susceptibility to carbapenems in P. aeruginosa. These subpopulations were initially indicated as mature subcolonies of lower susceptibility or resistance. Subsequently, the heterogeneous subclones were demonstrated by using a detailed population analysis. The assay showed the presence of multiple subpopulations with a virtually continuous spectrum of intermediate MICs between the MIC of the majority of the cells and the MIC for the most highly resistant subclones. The latter subclones exhibited substantially higher levels of resistance than the parental strains, in contrast to a previous observation in A. baumannii, where parental and daughter isolates had similar susceptibility profiles (Pournaras et al., 2005a) . Furthermore, the heterogeneous subpopulations retained their resistance levels implying a rather stable expression of the phenotype similar to heteroresistance to vancomycin in enterococci (Alam et al., 2001 ).
The heterogeneously carbapenem-resistant pseudomonads pose a challenge in terms of treatment. The optimization of meropenem administration regimens to suppress resistant P. aeruginosa mutants has been recently proposed (Tam et al., 2005) . Carbapenem-resistant subpopulations might thus proliferate preferentially and lead to treatment failure or recurrence of infection. It is plausible that an association exists between the frequency of heterogeneous compositions and the emergence of resistant mutants during exposures to drug levels not far exceeding the MIC of the organisms. In our region the extensive use of carbapenems for multidrugresistant P. aeruginosa infections may have contributed to the frequent carbapenem-heteroresistant phenotype. Although a carbapenem-resistant P. aeruginosa strain did not emerge from any of our patients, the detection of heterogeneous growth in susceptibility assays would be of major importance. Conventional agar dilution MICs using the standard 10 4 per spot inoculum may miss carbapenemresistant mutants with lower rates of occurrence. In such cases, higher inocula or prolonged incubation time might be used to define more precisely the highest drug concentration where resistant colonies occur and allow the administration of appropriately higher carbapenem dosages to suppress amplification of the resistant subclones.
